{"filings":[{"id":1222557,"accession_number":"0001213900-26-071111","cik":778164,"company_name":"Alto Ingredients, Inc.","ticker":"ALTO","form_type":"8-K","filed_at":"2026-06-23T20:18:22+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Alto Ingredients stockholders approve 2026 Omnibus Incentive Plan; directors elected","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["2026 Omnibus Incentive Plan approved, authorizing up to 7,000,000 shares; replaces 2016 plan, expires 2036.","All five director nominees elected: Nathan, McGregor, Nury, Gray, Tank; broker non-votes ~20.9M each.","Say-on-pay advisory resolution passed with 25.7M for, 1.0M against; 20.9M broker non-votes.","Ratification of RSM US LLP as independent auditor for FY2026 approved: 47.3M for, 1.0M against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":410676044.6934867,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":98795,"accession_number":"0001213900-26-052830","cik":778164,"company_name":"Alto Ingredients, Inc.","ticker":"ALTO","form_type":"8-K","filed_at":"2026-05-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Alto Ingredients swings to Q1 net income of $4.0M; adjusted EBITDA positive $4.7M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income of $4.0M ($0.05/diluted share) vs net loss of $12.0M in Q1 2025.","Gross profit of $9.2M improved $11.0M from a gross loss of $1.8M a year ago, helped by an $8.1M unrealized derivative gain.","Adjusted EBITDA of $4.7M vs negative $4.4M in Q1 2025; net sales $224.7M, down slightly from $226.5M.","Management cited strong export sales, higher crush margins, and Section 45Z tax credits as drivers of profitability.","Cash $20.3M at March 31, 2026; borrowing availability $94.3M including $29.3M revolver and $65M term loan."],"consensus_eps_estimate":null,"consensus_eps_actual":0.05,"consensus_revenue_estimate":null,"consensus_revenue_actual":224680000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":410676044.6934867,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":114469,"accession_number":"0001213900-26-023650","cik":778164,"company_name":"Alto Ingredients, Inc.","ticker":"ALTO","form_type":"8-K","filed_at":"2026-03-04T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Alto Ingredients swings to Q4 net income $21.5M from loss $42.0M; Adj EBITDA $27.9M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net income $21.5M ($0.28/diluted) vs net loss $42.0M ($0.57) in Q4 2024; gross profit $15.2M (from -$1.4M).","Full year 2025 net income $12.1M ($0.16/diluted) vs net loss $60.3M ($0.82); Adj EBITDA $44.7M (from -$8.5M).","Q4 net sales $232.0M, slightly down from $236.3M; cost of goods sold decreased to $216.8M from $237.7M.","Cash and equivalents $23.4M at Dec 31, 2025 vs $35.5M a year ago; borrowing availability $102M.","CEO cites higher crush margins, 45Z credits, strong renewable fuel exports for improved performance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":410676044.6934867,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":130842,"accession_number":"0001213900-25-115108","cik":778164,"company_name":"Alto Ingredients, Inc.","ticker":"ALTO","form_type":"8-K","filed_at":"2025-11-26T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Alto Ingredients director Jeremy Bezdek resigns from board effective Nov 24, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Jeremy T. Bezdek resigned from Board of Directors and all committees effective November 24, 2025.","Resignation was not due to any disagreement with Alto Ingredients regarding operations, policies, or practices.","No replacement has been announced as of the filing date."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":410676044.6934867,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":130841,"accession_number":"0001213900-25-106654","cik":778164,"company_name":"Alto Ingredients, Inc.","ticker":"ALTO","form_type":"8-K","filed_at":"2025-11-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Alto Ingredients swings to Q3 net income of $13.9M; gross profit triples to $23.5M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income of $13.9M ($0.19 per share) vs net loss of $2.8M in Q3 2024.","Gross profit increased to $23.5M from $6.0M; cost of goods sold down to $217.5M.","Adjusted EBITDA rose to $21.4M from $12.2M, driven by all-segment improvement.","Net sales fell slightly to $241M from $251.8M, offset by cost cuts and product mix.","Cash at $32.5M; borrowing availability of $85M ($20M revolver, $65M term loan)."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.13,"consensus_revenue_estimate":null,"consensus_revenue_actual":685962000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":410676044.6934867,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":147412,"accession_number":"0001213900-25-072564","cik":778164,"company_name":"Alto Ingredients, Inc.","ticker":"ALTO","form_type":"8-K","filed_at":"2025-08-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Alto Ingredients Q2 2025 net loss widens to $11.3M ($0.15/share) vs $3.4M loss YoY; sales down 7.6%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $218.4M vs $236.5M YoY; gross loss $1.9M vs gross profit $7.6M; net loss $11.3M ($0.15/share) vs $3.4M ($0.05/share).","Adjusted EBITDA negative $0.2M including $4.7M realized derivatives gains, vs negative $5.9M including $2.9M realized losses.","Cash $29.8M at June 30, 2025 vs $35.5M at Dec 31, 2024; borrowing availability $70M (term loan $65M, line $5M).","Corporate reorganization exceeded annualized savings goal of ~$8M; Western assets gross profit grew $5.6M YoY.","Potential 45Z credits up to ~$18M for two plants in next two years based on nameplate and carbon intensity scores."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.31,"consensus_revenue_estimate":null,"consensus_revenue_actual":444976000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":410676044.6934867,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":166042,"accession_number":"0001213900-25-058625","cik":778164,"company_name":"Alto Ingredients, Inc.","ticker":"ALTO","form_type":"8-K","filed_at":"2025-06-27T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Alto Ingredients regains Nasdaq compliance after stock bid price above $1.00 for 10 days","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Nasdaq notified Alto on June 23, 2025, that bid price closed above $1.00 for 10 consecutive business days.","Company has regained compliance with Nasdaq Listing Rule 5550(a)(2); delisting matter is closed.","Common stock (ALTO) remains listed on Nasdaq Capital Market."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":410676044.6934867,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":166041,"accession_number":"0001213900-25-057814","cik":778164,"company_name":"Alto Ingredients, Inc.","ticker":"ALTO","form_type":"8-K","filed_at":"2025-06-25T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Alto Ingredients shareholders elect six directors, approve say-on-pay, ratify auditor at 2025 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All six director nominees elected: Bryon T. McGregor, Maria G. Gray, Gilbert E. Nathan, Dianne S. Nury, Jeremy T. Bezdek, Alan R. Tank.","Say-on-pay approved with ~20.6M for (73% of votes cast), against 7.3M, abstain 0.5M.","Advisory vote on executive compensation frequency set at one year (19.7M votes for one year).","Ratification of RSM US LLP as independent auditor for FY2025: 47.7M for, 2.3M against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":410676044.6934867,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":166040,"accession_number":"0001213900-25-047350","cik":778164,"company_name":"Alto Ingredients, Inc.","ticker":"ALTO","form_type":"8-K","filed_at":"2025-05-23T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Alto Ingredients receives Nasdaq bid-price deficiency notice; 180 days to cure","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Common stock bid price below $1.00 for 30 consecutive business days as of May 19, 2025.","Company has 180 calendar days, until November 15, 2025, to regain compliance.","Compliance requires closing at $1.00+ for at least 10 consecutive business days.","If not cured by Nov 15, may qualify for additional 180-day period subject to other listing standards.","Potential delisting if unable to cure; company may appeal to Nasdaq Hearings Panel."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":410676044.6934867,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":166039,"accession_number":"0001213900-25-040642","cik":778164,"company_name":"Alto Ingredients, Inc.","ticker":"ALTO","form_type":"8-K","filed_at":"2025-05-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Alto Q1 net loss $12M; adjusted EBITDA improves to -$4.4M from -$7.1M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $226.5M, down 5.9% YoY from $240.6M; gross loss narrowed to $1.8M from $2.4M.","Net loss $12.0M ($0.16/sh) flat YoY; adjusted EBITDA improved to -$4.4M from -$7.1M.","Acquisition of Alto Carbonic CO2 plant and corporate reorganization on track to save ~$8M annually starting Q2 2025.","Increased ISCC renewable fuel sales into Europe at premium; partially offset domestic softening.","Cash $26.8M at March 31, 2025; borrowing availability $76.7M."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.16,"consensus_revenue_estimate":null,"consensus_revenue_actual":226540000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":410676044.6934867,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":183571,"accession_number":"0001213900-25-024771","cik":778164,"company_name":"Alto Ingredients, Inc.","ticker":"ALTO","form_type":"8-K","filed_at":"2025-03-18T23:59:59+00:00","items":["1.01","5.02","9.01"],"status":"ready","headline":"Alto Ingredients settles with activist Radoff/Torok; two directors not standing for re-election","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Chairman Douglas L. Kieta and director Michael D. Kandris will not stand for re-election at June 25, 2025 annual meeting.","Board will have sole discretion to fill the vacancies created by their departures.","Radoff/Torok Group agrees to vote for Board nominees and abide by standstill through 2026 annual meeting.","Standstill restricts Radoff/Torok from acquiring >19.9% of ALTO, nominating directors, or soliciting proxies.","No disagreements with company operations or policies cited; departures are part of the agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":410676044.6934867,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":183570,"accession_number":"0001213900-25-020724","cik":778164,"company_name":"Alto Ingredients, Inc.","ticker":"ALTO","form_type":"8-K","filed_at":"2025-03-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Alto Ingredients Q4 net loss $42M; idles Magic Valley, considers merger","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net loss $42.0M ($0.57/shr) in Q4 2024 vs $19.3M ($0.26/shr) a year ago; FY net loss $60.3M.","Adjusted EBITDA negative $7.7M in Q4 vs positive $3.5M in Q4 2023.","Cold idled Magic Valley plant; reduced headcount 16%; expects $8M annual savings from Q2 2025.","Acquired beverage-grade liquid CO2 processor adjacent to Columbia site on Jan 1, 2025; payback <2 years.","Considering asset sales, merger or other strategic transactions with financial advisors."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":410676044.6934867,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":200152,"accession_number":"0001213900-24-096835","cik":778164,"company_name":"Alto Ingredients, Inc.","ticker":"ALTO","form_type":"8-K","filed_at":"2024-11-12T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Alto Ingredients subsidiary enters CO2 transport/sequestration deal with Vault Dragon CCS","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["Alto Pekin will deliver CO2 to Vault Dragon's planned pipeline and sequestration facilities for permanent storage.","Agreement designed to allow Alto to qualify for and claim 45Q tax credits for carbon sequestration.","Specific commercial terms (service fees, minimum volumes, credit support) are redacted as confidential.","Vault is responsible for constructing and operating the transportation and injection facilities; Alto for the capture facility.","Includes deficit credits, bonus volumes, and force majeure provisions; term extends through the 45Q period."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":410676044.6934867,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":200151,"accession_number":"0001213900-24-094999","cik":778164,"company_name":"Alto Ingredients, Inc.","ticker":"ALTO","form_type":"8-K","filed_at":"2024-11-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Alto Ingredients Q3 net loss narrows to $2.8M; signs CO2 sequestration deal","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net loss available to common stockholders of $2.8M ($0.04 per share), improved from $3.8M ($0.05) in Q3 2023.","Net sales fell to $251.8M from $318.1M YoY; gross profit rose to $6.0M from $4.2M.","Adjusted EBITDA positive $12.2M in Q3, but nine-month adjusted EBITDA negative $0.8M.","Entered CO2 Transportation and Sequestration Agreement with Vault 44.01 for Pekin campus storage into Mt. Simon sandstone.","Cash and equivalents ended Q3 at $33.6M; total borrowing availability was $92.2M."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.25,"consensus_revenue_estimate":null,"consensus_revenue_actual":728911000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":410676044.6934867,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":216169,"accession_number":"0001213900-24-065684","cik":778164,"company_name":"Alto Ingredients, Inc.","ticker":"ALTO","form_type":"8-K","filed_at":"2024-08-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Alto Ingredients Q2 net loss $3.4M on $236.5M revenue; Adjusted EBITDA -$5.9M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net loss available to common stockholders $3.4M ($0.05/share) vs net income $7.2M ($0.10/share) a year ago.","Net sales $236.5M, down 25.5% from $317.3M in Q2 2023; gross profit fell to $7.6M from $17.2M.","Adjusted EBITDA negative $5.9M, including $5.4M Pekin outage costs and $2.9M realized derivative losses.","Pekin Campus delivered over $10M gross profit despite $5M+ in outage expenses; CEO cites favorable summer economics.","July crush margins more than doubled vs Q2; management expects positive Adjusted EBITDA in Q3 if margins hold."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.21,"consensus_revenue_estimate":null,"consensus_revenue_actual":477097000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":410676044.6934867,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":235704,"accession_number":"0001213900-24-054286","cik":778164,"company_name":"Alto Ingredients, Inc.","ticker":"ALTO","form_type":"8-K","filed_at":"2024-06-20T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Alto Ingredients shareholders elect directors, approve say-on-pay and stock plan increase","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All six director nominees elected: Douglas L. Kieta, Bryon T. McGregor, Michael D. Kandris, Maria G. Gray, Gilbert E. Nathan, Dianne S. Nury.","Say-on-pay approved: 26,055,415 votes for, 9,024,331 against, 217,420 abstain.","Stock plan amendment approved: authorized shares increased from 11.4M to 15.2M (33% increase).","Ratification of RSM US LLP as auditor: 49,027,666 votes for, 1,253,050 against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.15,"market_cap_usd":410676044.6934867,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":235703,"accession_number":"0001213900-24-040099","cik":778164,"company_name":"Alto Ingredients, Inc.","ticker":"ALTO","form_type":"8-K","filed_at":"2024-05-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Alto Ingredients Q1 net loss $12.0M; revenue $240.6M down 23% YoY","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $240.6M vs $313.9M YoY; net loss $12.0M ($0.17/sh) vs $13.5M ($0.18/sh).","Gross loss improved to $2.4M (includes $4.9M energy hedging loss) from $3.2M; Adjusted EBITDA -$7.1M vs -$10.4M.","Operating loss $10.3M vs $11.6M; weather factors and hedging loss impacted quarter.","CCS initiative progressing: LOI with Vault 44.01, negotiating terms, EPA Class VI permit submitted.","Cash $29.3M at March 31, 2024 vs $30.0M at Dec 31, 2023; borrowing availability $90.9M."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.17,"consensus_revenue_estimate":null,"consensus_revenue_actual":240629000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":410676044.6934867,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":253466,"accession_number":"0001213900-24-025790","cik":778164,"company_name":"Alto Ingredients, Inc.","ticker":"ALTO","form_type":"8-K","filed_at":"2024-03-26T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Alto Ingredients adopts performance-based equity compensation tied to Adjusted EBITDA ROA for FY2024-2026","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Compensation Committee adopted performance-based restricted stock program using Adjusted EBITDA ROA (4.80% threshold, 5.20% target, 5.60% max for 2024).","Awards to execs: Bryon McGregor (max 155,320 shares), Robert Olander (max 55,320), Auste Graham (max 48,000), James Sneed (max 48,000).","Time-based restricted stock also granted: McGregor 233,330 shares, Olander 83,330, Graham 71,660, Sneed 71,660 vesting 33%/33%/34% through 2027.","Vesting schedule: 33% of award earned per year based on performance; remaining shares subject to time vesting until early 2027."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":410676044.6934867,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":253465,"accession_number":"0001213900-24-024519","cik":778164,"company_name":"Alto Ingredients, Inc.","ticker":"ALTO","form_type":"8-K","filed_at":"2024-03-21T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Alto Ingredients names Todd E. Benton COO; Kandris resigns as interim COO, retiring June 20","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Michael D. Kandris resigns as Interim COO effective April 1, 2024; will retire on June 20, 2024; severance benefits removed via amendment.","Todd E. Benton appointed COO effective April 1, 2024; previously VP of Operations with 30 years in corn wet milling and ethanol.","Benton's base salary set at $350,000; eligible for short-term incentive target of 60% of base and long-term incentive target of $333,000.","Upon termination without cause or resignation for good reason, Benton receives 12 months base plus 100% STI; 24 months plus 200% STI in a change of control."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":410676044.6934867,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":253464,"accession_number":"0001213900-24-021413","cik":778164,"company_name":"Alto Ingredients, Inc.","ticker":"ALTO","form_type":"8-K","filed_at":"2024-03-11T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Alto Ingredients reports Q4 net loss $19.3M, FY gross profit $15.7M; signs LOI for CO2 storage","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net loss $0.26 per share vs $0.46; FY net loss $0.40 vs $0.60.","FY 2023 gross profit $15.7M vs gross loss $27.6M; Q4 gross loss $2.5M vs $21.3M loss.","Q4 adjusted EBITDA $3.5M vs negative $15.5M; FY adjusted EBITDA $20.8M vs negative $5.7M.","Signed LOI with Vault 44.01 for permanent CO2 storage near Pekin campus to reduce carbon emissions.","Temporarily hot-idled Magic Valley facility in Q1 2024 to install design upgrades; restart expected in Q2 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":410676044.6934867,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":253463,"accession_number":"0001213900-24-020254","cik":778164,"company_name":"Alto Ingredients, Inc.","ticker":"ALTO","form_type":"8-K","filed_at":"2024-03-06T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Alto Ingredients amends bylaws to update proxy rules and add exclusive forum provision","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Board approved amended bylaws effective Feb 29, 2024, revising advance notice procedures and disclosure requirements.","New provisions mandate compliance with SEC Rule 14a-19 for proxy solicitations supporting non-Board nominees.","Stockholders soliciting proxies must use a non-white proxy card; stockholder list inspection requirement eliminated per DGCL amendments.","Federal district courts designated as exclusive forum for claims under the Securities Act of 1933.","Technical and clarifying changes made to align with universal proxy rules and Delaware law."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":410676044.6934867,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":270929,"accession_number":"0001213900-23-083888","cik":778164,"company_name":"Alto Ingredients, Inc.","ticker":"ALTO","form_type":"8-K","filed_at":"2023-11-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Alto Ingredients Q3 net loss narrows to $3.8M; Adjusted EBITDA turns positive $4.7M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $318.1M vs $336.9M YoY; gross profit improved to $4.2M from a loss of $19.8M.","Net loss $0.05 per share vs $0.39 YoY; includes $2.8M USDA grant.","Adjusted EBITDA of $4.7M vs negative $20.6M YoY; operating cash flow positive.","Extends EBITDA expansion goals by 6-12 months due to higher yeast project costs and inflation.","Cash $26.2M at Sep 30, 2023; total borrowing availability of $93.4M."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.14,"consensus_revenue_estimate":null,"consensus_revenue_actual":949315000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":410676044.6934867,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":287829,"accession_number":"0001213900-23-078075","cik":778164,"company_name":"Alto Ingredients, Inc.","ticker":"ALTO","form_type":"8-K","filed_at":"2023-09-20T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Alto Ingredients amends employment terms for CEO ($525k base), CFO ($325k), and Interim COO ($528k)","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CEO Bryon McGregor: $525k base salary (retro to Aug 1), 70% STI target, $700k LTI target, 150k shares vesting 2024-2026.","CFO Robert Olander: $325k base salary (retro to Aug 1), 50% STI target, $250k LTI target, 58.5k shares vesting 2024-2026.","Interim COO Michael Kandris: $528k base salary, 70% STI target; employment auto-terminates July 31, 2024 if not earlier ended.","Non-CIC severance: CEO gets 18 months base + 150% STI; CFO/COO get 12 months base + 100% STI."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":410676044.6934867,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":287828,"accession_number":"0001213900-23-064073","cik":778164,"company_name":"Alto Ingredients, Inc.","ticker":"ALTO","form_type":"8-K","filed_at":"2023-08-07T23:59:59+00:00","items":["2.02","5.02","7.01","9.01"],"status":"ready","headline":"Alto Ingredients posts Q2 net income $7.2M; appoints Bryon McGregor as CEO and Robert Olander as CFO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Q2 net sales $317.3M (down 12% YoY); net income $7.2M/$0.10 diluted EPS vs $21.5M/$0.29 incl. $22.7M USDA grant.","Adjusted EBITDA $15.5M vs $29.9M (incl. $22.7M grant); operating income $9.3M vs prior loss of $152,000.","Expects positive adjusted EBITDA in Q3 2023; targets annual EBITDA increase of $125M by end of 2026 via carbon capture and other projects.","Bryon McGregor (former CFO) appointed President/CEO effective Aug 1; Michael Kandris retired as CEO, appointed Interim COO for up to one year.","Robert Olander (former VP, Corporate Controller) appointed CFO effective Aug 1."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":410676044.6934867,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":308154,"accession_number":"0001213900-23-050987","cik":778164,"company_name":"Alto Ingredients, Inc.","ticker":"ALTO","form_type":"8-K","filed_at":"2023-06-22T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Alto Ingredients shareholders elect five directors, approve say-on-pay and stock plan increase","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All five director nominees elected: Kandris, Gray, Kieta, Nathan, Nury.","Say-on-pay advisory vote approved: 31.5M for, 6.1M against.","Amendment to 2016 Stock Incentive Plan passed, raising authorized shares from 8.9M to 11.4M.","Ratification of RSM US LLP as auditor approved: 51.7M for, 1.2M against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":410676044.6934867,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":308153,"accession_number":"0001213900-23-037349","cik":778164,"company_name":"Alto Ingredients, Inc.","ticker":"ALTO","form_type":"8-K","filed_at":"2023-05-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Alto Ingredients Q1 net loss $13.5M, Adjusted EBITDA -$4.5M; expects positive Q2","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $313.9M, gross loss $3.2M vs gross profit $4.8M a year ago.","Net loss available to common $13.5M ($0.18/share) vs $2.9M ($0.04) in Q1 2022.","Adjusted EBITDA negative $4.5M, down from positive $4.4M in prior-year period.","Cash $21.2M; $40M term loan available (up to $65M with accordion).","CEO expects positive Adjusted EBITDA in Q2 2023 based on current ethanol crush margins."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.18,"consensus_revenue_estimate":null,"consensus_revenue_actual":313891000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":410676044.6934867,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":327033,"accession_number":"0001213900-23-018888","cik":778164,"company_name":"Alto Ingredients, Inc.","ticker":"ALTO","form_type":"8-K","filed_at":"2023-03-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Alto Ingredients Q4 2022 net loss $33.4M vs income $35.4M; FY net loss $42.9M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net sales $328.4M down from $385.5M; gross loss $21.3M vs gross profit $42.1M.","Full-year net loss $42.9M ($0.60/sh) vs net income $44.2M ($0.61/sh); adjusted EBITDA -$9.8M vs +$76.8M.","CEO cites commodity price swings; growth initiatives target $65M+ EBITDA by 2025, $125M+ by 2026.","Term loan facility of up to $125M signed Nov 2022; $40M remaining availability plus $57.9M ABL capacity.","Cash and equivalents $36.5M at Dec 31, 2022, down from $50.6M at Dec 31, 2021."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":410676044.6934867,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":344758,"accession_number":"0001213900-22-072157","cik":778164,"company_name":"Alto Ingredients, Inc.","ticker":"ALTO","form_type":"8-K","filed_at":"2022-11-14T23:59:59+00:00","items":["1.01","2.03","3.02","9.01"],"status":"ready","headline":"Alto Ingredients secures $125M credit facility, amends ABL credit agreement","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Entered into $125M senior secured term loan facility with Orion Infrastructure Capital; initial advance up to $100M.","Facility bears interest at 10% fixed per annum, matures November 2028.","Issued 1,282,051 shares of common stock to lenders; up to 320,513 additional shares for CapEx loans.","Amended existing ABL credit agreement with Wells Fargo: maturity extended to 2027, fixed charge coverage ratio reduced to 1.10x, distribution limit increased to 75% of excess cash flow."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":410676044.6934867,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":344757,"accession_number":"0001213900-22-069768","cik":778164,"company_name":"Alto Ingredients, Inc.","ticker":"ALTO","form_type":"8-K","filed_at":"2022-11-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Alto Ingredients Q3 net loss $28.4M; secures $125M debt facility for growth","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales rose 10% YoY to $336.9M, but gross loss widened to $19.8M from $3.4M.","Net loss available to common stockholders was $28.4M ($0.39/sh), vs $3.5M loss ($0.05/sh) in Q3 2021.","Adjusted EBITDA was negative $20.6M, compared to positive $3.0M a year ago.","Cash and equivalents fell to $28.5M at Sept 30, 2022 from $50.6M at Dec 31, 2021.","Debt facility up to $125M (6-year term loan) to fund carbon capture, yeast production, and energy projects."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.13,"consensus_revenue_estimate":null,"consensus_revenue_actual":1007184000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":410676044.6934867,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":361237,"accession_number":"0001213900-22-045429","cik":778164,"company_name":"Alto Ingredients, Inc.","ticker":"ALTO","form_type":"8-K","filed_at":"2022-08-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Alto Ingredients Q2 net sales $362.2M (+21% YoY), net income $21.5M, adj. EBITDA $29.9M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $362.2M, up 21% from $298.1M in Q2 2021.","Net income $21.5M ($0.29 diluted EPS) vs $8.0M ($0.11) in prior year.","Gross profit $8.8M vs $15.2M; includes $22.7M USDA Biofuel Producer Program cash grant.","Adjusted EBITDA $29.9M, up from $17.0M in Q2 2021.","Cash and equivalents $57.4M; working capital $178.4M at June 30, 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":0.26,"consensus_revenue_estimate":null,"consensus_revenue_actual":670307000.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":410676044.6934867,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":380483,"accession_number":"0001213900-22-034606","cik":778164,"company_name":"Alto Ingredients, Inc.","ticker":"ALTO","form_type":"8-K","filed_at":"2022-06-23T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Alto Ingredients shareholders elect directors, approve say-on-pay and stock plan increase","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All seven director nominees elected; broker non-votes 15,050,880 for each.","Say-on-pay advisory resolution passed with 16,331,462 for vs 15,654,754 against.","Stock plan amendment approved: authorized shares increased from 7.4M to 8.9M.","Ratification of RSM US LLP as auditor for 2022: 46,177,303 for, 1,012,679 against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":410676044.6934867,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":380482,"accession_number":"0001213900-22-030730","cik":778164,"company_name":"Alto Ingredients, Inc.","ticker":"ALTO","form_type":"8-K","filed_at":"2022-06-01T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Alto Ingredients SVP Christopher Wright retires, signs one-year consulting deal at $5K biweekly","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Christopher W. Wright, Senior Vice President and former General Counsel, retired as employee effective May 27, 2022.","Consulting Agreement effective May 28, 2022, for one year; provides advice to CEO, CFO, or General Counsel.","Biweekly retainer of $5,000; additional project fees may be agreed separately in writing.","Wright remains subject to confidentiality obligations and restrictions on trading ALTO securities."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":410676044.6934867,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":380481,"accession_number":"0001213900-22-024871","cik":778164,"company_name":"Alto Ingredients, Inc.","ticker":"ALTO","form_type":"8-K","filed_at":"2022-05-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Alto Ingredients Q1 net sales up 41% to $308M but net loss of $2.9M vs prior-year profit","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $308.1M (+41% YoY); cost of goods sold $303.3M (+48% YoY).","Gross profit fell to $4.8M from $13.8M; operating loss $2.9M vs income $5.6M.","Net loss available to common $2.9M ($0.04 per share) vs net income $4.4M ($0.06).","Adjusted EBITDA $4.4M vs $13.4M; cash $36.2M, down from $50.6M at year-end.","Acquired small-package spirits distributor Eagle Alcohol; launched quality and ESG initiatives."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.04,"consensus_revenue_estimate":null,"consensus_revenue_actual":308118000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":410676044.6934867,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":398566,"accession_number":"0001213900-22-011585","cik":778164,"company_name":"Alto Ingredients, Inc.","ticker":"ALTO","form_type":"8-K","filed_at":"2022-03-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Alto Ingredients reports Q4 net income $35.4M vs loss $20.5M; full year net sales up 35% to $1.2B","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net sales $385.5M (+128% YoY); gross profit $42.1M (+209%); net income $0.49 diluted EPS vs loss $0.30.","Full year net sales $1.2B (+35%); net income $44.2M ($0.61 diluted EPS) vs loss $16.4M; adjusted EBITDA $77M.","Acquired specialty alcohol distributor Eagle Alcohol in Jan 2022; sold Stockton facility for $24M in Nov 2021.","CEO Mike Kandris cites focus on higher-margin markets; company now profitable with growth opportunities."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":410676044.6934867,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":417576,"accession_number":"0001213900-21-058137","cik":778164,"company_name":"Alto Ingredients, Inc.","ticker":"ALTO","form_type":"8-K","filed_at":"2021-11-10T23:59:59+00:00","items":["1.01"],"status":"ready","headline":"Alto Ingredients sells Stockton ethanol plant to Pelican Acquisition for $24M","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Sale of ethanol plant and related assets in San Joaquin County, CA to Pelican Acquisition LLC.","Total consideration of $24 million, subject to closing adjustments.","Transaction closed on November 5, 2021, the same date as the agreement.","Seller is subsidiary Pacific Ethanol Stockton LLC; parent Alto Ingredients guarantees certain provisions.","Asset Purchase Agreement includes customary representations, warranties, and covenants."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":410676044.6934867,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":417575,"accession_number":"0001213900-21-057728","cik":778164,"company_name":"Alto Ingredients, Inc.","ticker":"ALTO","form_type":"8-K","filed_at":"2021-11-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Alto Ingredients reports Q3 net loss of $3.5M, sells Stockton facility, retires $150M debt","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $305.6M (+49% YoY), but gross loss of $3.4M vs gross profit $20.9M in prior year.","Net loss $3.5M ($0.05/share) vs net income $14.9M ($0.24/diluted share) in Q3 2020.","Adjusted EBITDA $3.0M, down from $34.1M in Q3 2020; operating loss of $8.9M.","Sold Stockton CA facility for $24M cash on Nov 8; used proceeds to retire $150M term debt, now debt-free.","Completed projects expected to increase annual EBITDA by $18.5M starting 2022; yeast expansion and wet mill upgrades."],"consensus_eps_estimate":null,"consensus_eps_actual":0.12,"consensus_revenue_estimate":null,"consensus_revenue_actual":822400000.0,"consensus_period":"2021-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":410676044.6934867,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}